Non–Small Cell Lung Cancer, Version 2.2013
David S. Ettinger(Sidney Kimmel Comprehensive Cancer Center), Wallace Akerley(University of Utah), Hossein Borghaei(Fox Chase Cancer Center), Andrew C. Chang(University of Michigan–Ann Arbor), Richard T. Cheney(Roswell Park Comprehensive Cancer Center), Lucian R. Chirieac(Dana-Farber Brigham Cancer Center), Thomas A. D’Amico(Duke Cancer Institute), Todd L. Demmy(Roswell Park Comprehensive Cancer Center), Ramaswamy Govindan(Jewish Hospital), Frederic W. Grannis(City of Hope), Stefan C. Grant(University of Alabama at Birmingham), Leora Horn(Vanderbilt-Ingram Cancer Center), Thierry Jahan(UCSF Helen Diller Family Comprehensive Cancer Center), Ritsuko Komaki(The University of Texas MD Anderson Cancer Center), Feng‐Ming Kong(University of Michigan–Ann Arbor), Mark G. Kris(Memorial Sloan Kettering Cancer Center), Lee M. Krug(Memorial Sloan Kettering Cancer Center), Rudy P. Lackner(Nebraska Medical Center), Inga T. Lennes(Massachusetts General Hospital), Billy W. Loo(Cancer Institute (WIA)), Renato Martins(Seattle Cancer Care Alliance), Gregory A. Otterson(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Jyoti D. Patel(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Mary Pinder-Schenck(Moffitt Cancer Center), Katherine M.W. Pisters(The University of Texas MD Anderson Cancer Center), Karen L. Reckamp(City of Hope), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Eric Rohren(The University of Texas MD Anderson Cancer Center), Theresa A. Shapiro(Sidney Kimmel Comprehensive Cancer Center), Steven Swanson(Dana-Farber Brigham Cancer Center), Kurt W. Tauer(University of Tennessee at Knoxville), Douglas E. Wood(Seattle Cancer Care Alliance), Stephen C. Yang(Sidney Kimmel Comprehensive Cancer Center), Kristina M. Gregory(National Comprehensive Cancer Network), Miranda Hughes(National Comprehensive Cancer Network)
Cited by 452
Abstract
These NCCN Guidelines Insights focus on the diagnostic evaluation of suspected lung cancer. This topic was the subject of a major update in the 2013 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer. The NCCN Guidelines Insights focus on the major updates in the NCCN Guidelines and discuss the new updates in greater detail.
Related Papers
No related papers found
Powered by citation graph analysis